Quick Answer
Milestone Pharmaceuticals Inc. reported Common Stock Shares Outstanding of 106.24 million shares for the year ending 2025.
- Milestone Pharmaceuticals Inc. showed an increase of +99.1% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Milestone Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: 614,940 shares | Q2 2019: 24.49 million shares | Q3 2019: 24.49 million shares | Q1 2020: 24.56 million shares | Q2 2020: 24.69 million shares | Q3 2020: 24.73 million shares | Q1 2021: 29.85 million shares | Q2 2021: 29.85 million shares | Q3 2021: 29.87 million shares | Q1 2022: 29.92 million shares | Q2 2022: 30.01 million shares | Q3 2022: 30.39 million shares | Q1 2023: 33.34 million shares | Q2 2023: 33.36 million shares | Q3 2023: 33.48 million shares | Q1 2024: 53.25 million shares | Q2 2024: 53.27 million shares | Q3 2024: 53.33 million shares | Q1 2025: 53.46 million shares | Q2 2025: 53.49 million shares | Q3 2025: 85.17 million shares.
- Over the full 8 years of available data (2018 to 2025), Milestone Pharmaceuticals Inc.'s Common Stock Shares Outstanding has grown by 17,701.4%.
- Historical annual values: Fiscal year 2025: 106.24 million shares | Fiscal year 2024: 53.35 million shares | Fiscal year 2023: 33.48 million shares | Fiscal year 2022: 34.29 million shares | Fiscal year 2021: 29.90 million shares | Fiscal year 2020: 29.83 million shares | Fiscal year 2019: 24.51 million shares | Fiscal year 2018: 596,787 shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: